Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Popular Articles

Appeal For Cancer Patients To Trial New Nail Damage Remedy
The search is on for fifty cancer patients undergoing chemo or radiotherapy to trial an innovative, natural cosmetic product, Evonail, aimed at reversing the damage done to cracked or broken nails during anti-cancer treatments.
generic viagra online
Cal/OSHA Standards Become First In The Nation Protections Against Infectious Airborne Diseases
The nation"s first standard to safeguard workers from the spread of airborne diseases was approved yesterday by California"s Office of Administrative Law and filed with the Secretary of State. With full support from labor and management stakeholders, on May 21 the Cal/OSHA Standards Board unanimously approved the Aerosol Transmissible Disease (ATD) standard which is designed to protect workers in healthcare and related industries from the spread of diseases such as tuberculosis, measles, influenza, and other pathogens spread by coughing and sneezing. The standard becomes effective on August 5.
News of the day
Small Clinical Trial Examines Drug's Ability To Reduce HIV In Body
In the first human trial of GlaxoSmithKline"s (GSK) experimental HIV drug S/GSK1349572, the drug was able to reduce HIV to undetectable levels in 70 percent of the 35 patients taking the treatment for 10 days, according to findings presented at the International AIDS Society"s conference in Cape Town, South Africa, Bloomberg reports. The drug decreased the virus in the body "without the signs of resistance linked to treatments from" Merck"s Isentress and Gilead Sciences" Elvitegravir, according to Bloomberg. GSK will begin a larger trial of the drug this month, Sherene Min, the director of clinical pharmacology discovery medicine for GSK, said. Michael Saag, director of the Center for AIDS Research at the University of Alabama, who is not affiliated with the study, said the scale of viral reduction was "spectacular," adding, "In 10 days to go to undetectable is pretty strong. This thing"s working" (Bennett, 7/21).
Cardiovascular

Warning To Consumers About Recreational Use Of Medicines, Australia

The National Prescribing Service (NPS) warns people are playing Russian roulette with their health when they take medicines inappropriately. Media reports this week about people mixing sleeping tablet, zolpidem (Stilnox), with energy drink Red Bull™ have failed to highlight the risks people are taking when they intentionally misuse pharmaceuticals. NPS CEO, Dr Lynn Weekes says people should ensure they know the risks and benefits of any medicine before taking it. "All medicines have potential side effects and should only be used for the purpose in which they have been prescribed," Dr Weekes said. Zolpidem is a prescription medicine that is used to initiate and maintain sleep in those with sleeping difficulties. It has a number of common side effects, including drowsiness, dizziness, diarrhoea, nausea, vomiting, headache and muscle weakness. It has also been associated with reports of unusual and potentially dangerous behaviours during sleep. The consumer medicine information for Stilnox, which is written by the manufacturer, clearly states that Stilnox should not be taken if you have been drinking alcohol and it should not be given to people under the age of 18. "I strongly advise anyone who has been, or is thinking about, using any medicine for recreational purposes to read the consumer medicine information leaflet and think about the ramifications it may have on their health," Dr Weekes said. "There are many s for information about medicines including your pharmacist or GP, the NPS website and our publications." "Health professionals should also be aware of patients who may ask specifically for Stilnox following these latest media reports and ensure patients understand the purpose for which the medicine has been prescribed," Dr Weekes warned. Consumer medicine information leaflets can be viewed here. Additional information about zolpidem is available in the December 2008 edition of Australian Prescriber in "Hypnotic hazards: adverse effects of zolpidem and other z-drugs" by Professor LG Olson. To view the article visit here. The National Prescribing Service Limited


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009